BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Weggheleire A, An S, De Baetselier I, Soeung P, Keath H, So V, Ros S, Teav S, Smekens B, Buyze J, Florence E, van Griensven J, Thai S, Francque S, Lynen L. A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening. PLoS One 2017;12:e0183530. [PMID: 28832660 DOI: 10.1371/journal.pone.0183530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Henriot P, Castry M, Luong Nguyen LB, Shimakawa Y, Jean K, Temime L. Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures. Aliment Pharmacol Ther 2022;56:558-69. [PMID: 35758763 DOI: 10.1111/apt.17106] [Reference Citation Analysis]
2 E B, Ou P, Ouoba S, Hussain MRA, Ko K, Nagashima S, Sugiyama A, Akita T, Tanaka J. Prevalence and genotype distribution of viral hepatitis B in Cambodia between 1990 and 2020: a systematic review and meta-analysis. Arch Public Health 2022;80:119. [PMID: 35418163 DOI: 10.1186/s13690-022-00880-9] [Reference Citation Analysis]
3 Rupasinghe D, Choi JY, Kumarasamy N, Pujari S, Sun LP, Merati TP, Lee MP, Kinh NV, Kiertiburanakul S, Do CD, Avihingsanon A, Ross J, Jiamsakul A; o n behalf of IeDEA Asia-Pacific. Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific. HIV Med 2022. [PMID: 35218151 DOI: 10.1111/hiv.13280] [Reference Citation Analysis]
4 Pheng P, Meyer L, Ségéral O, Chea P, Yi S, Tuot S, Kaldor JM, Saphonn V. Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey. BMC Infect Dis 2022;22:177. [PMID: 35193496 DOI: 10.1186/s12879-022-07163-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Han SM, Por I, Samley K, Bunreth V, Smith C, Ariyoshi K, Dousset JP, Le Paih M. Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia. Western Pac Surveill Response J 2021;12:17-24. [PMID: 34703632 DOI: 10.5365/wpsar.2020.11.3.006] [Reference Citation Analysis]
6 De Weggheleire A, Buyze J, An S, Thai S, van Griensven J, Francque S, Lynen L. Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia. World J Hepatol 2021; 13(9): 1167-1180 [PMID: 34630883 DOI: 10.4254/wjh.v13.i9.1167] [Reference Citation Analysis]
7 Torpey K, Ogyiri L, Cuylaerts V, Agyeman S, Agyei-Nkansah A, Buyze J, Commey JO, Lynen L, De Weggheleire A. Hepatitis C Prevalence and Validation of a Clinical Prediction Score for Targeted Screening among People Living with HIV in Ghana. J Int Assoc Provid AIDS Care 2021;20:23259582211022469. [PMID: 34060369 DOI: 10.1177/23259582211022469] [Reference Citation Analysis]
8 Kwofie TB, Adigbli D, Osei-Yeboah J, Ativi E, Lokpo SY. Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity. Heliyon 2021;7:e07172. [PMID: 34141932 DOI: 10.1016/j.heliyon.2021.e07172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Irekeola AA, Malek NA, Wada Y, Mustaffa N, Muhamad NI, Shueb RH. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis. PLoS One 2021;16:e0251673. [PMID: 34014997 DOI: 10.1371/journal.pone.0251673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lynch E, Falq G, Sun C, Bunchhoeung PDT, Huerga H, Loarec A, Dousset JP, Marquardt T, Paih ML, Maman D. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey. BMC Infect Dis 2021;21:223. [PMID: 33637051 DOI: 10.1186/s12879-021-05826-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Vetter BN, Ongarello S, Tyshkovskiy A, Alkhazashvili M, Chitadze N, Choun K, Sokkab A, De Weggheleire A, Vanroye F, Reipold EI. Sensitivity and specificity of rapid hepatitis C antibody assays in freshly collected whole blood, plasma and serum samples: A multicentre prospective study. PLoS One 2020;15:e0243040. [PMID: 33270716 DOI: 10.1371/journal.pone.0243040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Saing CH, Prem K, Uk P, Chhoun P, Chann N, Tuot S, Mun P, Yi S. Risk factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia. Int J Drug Policy 2020;86:102974. [PMID: 33068831 DOI: 10.1016/j.drugpo.2020.102974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang M, O'Keefe D, Iwamoto M, Sann K, Kien A, Hang V, Brucker C, Jolivet P, Ly S, Chhit D, Balkan S, Marquardt T, Le Paih M, Dousset JP. High sustained viral response rate in patients with hepatitis C using generic sofosbuvir and daclatasvir in Phnom Penh, Cambodia. J Viral Hepat 2020;27:886-95. [PMID: 32358826 DOI: 10.1111/jvh.13311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 De Weggheleire A, De Baetselier I, An S, Goletti S, Suin V, Thai S, Francque S, Crucitti T, Lynen L, Van Gucht S, Kabamba BM. Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia. Infect Dis Ther 2020;9:657-67. [PMID: 32474893 DOI: 10.1007/s40121-020-00304-7] [Reference Citation Analysis]
15 Buyze J, Weggheleire A, van Griensven J, Lynen L. Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia. BMC Infect Dis 2020;20:209. [PMID: 32164581 DOI: 10.1186/s12879-020-4909-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khwairakpam G, Burry J. Strategies for access to affordable hepatitis C testing and treatment in Asia. Curr Opin HIV AIDS 2019;14:1-6. [PMID: 30480583 DOI: 10.1097/COH.0000000000000514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Mburu G, Chhoun P, Chann N, Tuot S, Mun P, Yi S. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey. Subst Abuse Treat Prev Policy 2019;14:42. [PMID: 31623645 DOI: 10.1186/s13011-019-0232-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
18 Rouet F, Nouhin J, Zheng DP, Roche B, Black A, Prak S, Leoz M, Gaudy-Graffin C, Ferradini L, Mom C, Mam S, Gautier C, Lesage G, Ken S, Phon K, Kerleguer A, Yang C, Killam W, Fujita M, Mean C, Fontenille D, Barin F, Plantier JC, Bedford T, Ramos A, Saphonn V. Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015. Clin Infect Dis 2018;66:1733-41. [PMID: 29211835 DOI: 10.1093/cid/cix1071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
19 Nouhin J, Iwamoto M, Prak S, Dousset JP, Phon K, Heng S, Kerleguer A, Le Paih M, Dussart P, Maman D, Rouet F. Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017. Sci Rep 2019;9:7314. [PMID: 31086236 DOI: 10.1038/s41598-019-43785-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
20 Huai P, Li F, Li Z, Sun L, Fu X, Pan Q, Yu G, Chai Z, Chu T, Mi Z, Bao F, Wang H, Zhou B, Wang C, Sun Y, Niu G, Zhang Y, Fu F, Lang X, Wang X, Zhao H, Liu D, Liu H, Liu D, Liu J, Xu A, Zhang F. Seroprevalence and associated factors of HSV-2 infection among general population in Shandong Province, China. BMC Infect Dis 2019;19:382. [PMID: 31060582 DOI: 10.1186/s12879-019-3995-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Yi S, Mun P, Chhoun P, Chann N, Tuot S, Mburu G. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey. Harm Reduct J 2019;16:29. [PMID: 31036011 DOI: 10.1186/s12954-019-0299-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]